A unit of MicroPort CardioFlow Medtech (HKG:2160) agreed to purchase the remaining 49% equity stake it does not already own in Shanghai MicroPort CardioAdvent for 170.9 million yuan, a Friday Hong Kong bourse filing said.
Shanghai MicroPort CardioFlow Medtech will buy a 35.27% stake from MicroPort Sinica and 13.73% from Shanghai Zuoqing Enterprise Management Consulting Service Centre.
Upon completion, it will own 100% of the target company, the filing said.
Shanghai MicroPort CardioAdvent is a high-tech medical device firm specializing in left atrial appendage devices.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。